|The White House Urges Greater Omega-3 Consumption|
It took seven years of intensive litigation to force the FDA to recognize the value of fish oil. There are too many new compounds that may prevent and treat disease to allow a central bureaucracy with a proven track record of failure to continue making life and death decisions for the American public.
Until recently, it was a criminal offense to promote omega-3 fatty acids to reduce cardiovascular disease risk. Now the White House is encouraging the FDA and other Federal agencies to do more to enlighten consumers about the benefits of omega-3 fatty acids and the dangers of trans fatty acids. The invariable question is, will future Presidential administrations encourage Americans to follow health concepts that the FDA is suppressing today? Are scientific pioneers sitting in American prisons whose original ideas will later show to be medically correct?
A free market solution
Consumers who want government “protection” could insist on only using FDA-approved products, while those who want to be more aggressive could experiment with products that would specifically state on their labels: “Not Approved By The FDA.”
This free choice system would release the creative energies of physician-scientists whose new ideas are presently silenced by fear of FDA persecution. We believe the result of this greater freedom would be a marvelous medical renaissance.
The FDA survives because of an apathetic American public who has grown so used to government incompetence that they feel little can be done to change it. The Life Extension Foundation, on the other hand, has proven that positive changes can occur at the Federal level if enough citizens speak up.
As a member of The Life Extension Foundation, you belong to an elite group who possess the knowledge to differentiate scientific authenticity from the political hyperbole long espoused by the FDA.
For longer life,
1. Garcia-Closas R, et al. Fish consumption, omega-3 fatty acids and the Mediterranean diet. Eur J Clin Nutr 1993 Sep;47 Suppl 1:S85-90.
2. Iso H, et al. Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA 2001 Jan 17;285(3):304-12.
3. Konard RJ, et al. Eicosapentaenoic acid (C20:5) augments glucose-induced insulin secretion from beta-TC3 insulinoma cells. Pancreas 1996 Oct;13(3):253-8.
4. Tsuda H; et al. Demonstration of organotropic effects of chemopreventive agents in multiorgan carcinogenesis models. IARC Sci Publ (FRANCE) 1996, (139) p143-50.
5. Lai PB, et al. Cell cycle arrest and induction of apoptosis in pancreatic cancer cells exposed to eicosapentaenoic acid in vitro. Br J Cancer 1996 Nov;74(9):1375-83.
6. Das UN. Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease. Prostaglandins Leukot Essent Fatty Acids. 1995 Jun;52(6):387-91.
7. Thorngren M, et al. Effects of 11-week increases in dietary eicosapentaenoic acid on bleeding time, lipids and platelet aggregation. Lancet (England) Nov 28 1981, 2 (8257) p1190-3.
8. Okuda Y, et al. Long-term effects of eicosapentaenoic acid on diabetic peripheral neuropathy and serum lipids in patients with type II diabetes mellitus. Journal of Diabetes and its Complications (USA), 1996, Sep-Oct;10(5):280-7.
9. Sinclair AJ, et al. Marine lipids: overview news insights and lipid composition of Lyprinol. Allerg Immunol (Paris) 2000 Sep;32(7):261-71.
10. Yam D, et al. The effect of omega-3 fatty acids on risk factors for cardiovascular diseases. Harefuah 2001 Dec;140(12):1156-8, 1230.
11. Connor WE. n-3 Fatty acids from fish and fish oil: panacea or nostrum? Am J Clin Nutr 2001 Oct;74(4):415-6.
12. Dyerberg J, Bang HO. A hypothesis on the development of acute myocardial infarction in Greenlanders. Scand J Clin Lab Invest Suppl 1982;161:7-13.
14. de Roos NM, et al. Replacement of dietary saturated fatty acids by trans fatty acids lowers serum HDL cholesterol and impairs endothelial function in healthy men and women. Arterioscler Thromb Vasc Biol 2001 Jul;21(7):1233-7.
15. Oomen CM, et al. Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet 2001 Mar 10;357(9258):746-51.